Retraction
Dual targeting of TGF-β and PD-L1 inhibits tumor growth in TGF-β/PD-L1-driven colorectal carcinoma
Paper Information
Record ID:
62807
Author(s):
Journal:
Publication Date:
June 30, 2023
Retraction Date:
November 17, 2024
(1.0 year years ago)
Subjects:
Institutions:
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
- Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
- Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
- Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
- Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
- Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
- College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq
- Australasian Nanoscience and Nanotechnology Initiative (ANNI), 8054 Monash University LPO, Clayton, Victoria, Australia
- Brighton & Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex, BN1 9PH, UK
- School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Kelvin Grove, Brisbane, QLD, 4059, Australia
- School of Mechanical, Medical and Process Engineering, Science and Engineering Faculty, Queensland University of Technology, 2 George St, Brisbane City QLD, 4000, Australia
- Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia
- Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam U.M.C., VU. University Medical Center (VUMC), Amsterdam, the Netherlands
- Cancer Pharmacology Lab, AIRC Start up Unit, Fondazione Pisana per La Scienza, Pisa, Italy
Article Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (12)
12
Total Citations1
Post-Retraction(8.3%)
11
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
1
Within 1 year
0
After 2+ years
12
Days since retraction (latest)
TGF-β in tumor microenvironment, metabolism, and immunotherapy
Haotian Bai, Yisong Y. Wan
Elsevier eBooks
Published: Nov 2024
12 days after retraction
Artificial intelligence and colorectal cancer drug resistance
Sikhumbuzo Z. Mbatha, Rupert Ecker, Zodwa Dlamini
Elsevier eBooks
Published: Nov 2024
9 days before retraction
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications
Angela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi et al. (10 authors)
Cancers
Open Access
Published: Oct 2024
4 citations
4 citations
28 days before retraction
WNT and TGF-Beta Pathway Alterations in Early-Onset Colorectal Cancer Among Hispanic Populations
Cecilia Monge, Brigette Waldrup, Francisco Carranza et al. (4 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Oct 2024
6 citations
6 citations
30 days before retraction
Advancing immunotherapy for intrahepatic cholangiocarcinoma: exploring the tumor immune microenvironment and innovative treatments
Pengcheng Wei, Li Zhao
Hepatoma Research
Open Access
Published: Sep 2024
1 citation
1 citation
52 days before retraction
Diagnostic, Prognostic, and Predictive Biomarkers in Gastric Cancer: from Conventional to Novel Biomarkers
Ghazaleh Khalili‐Tanha, Nima Khalili‐Tanha, Arian Karimi Rouzbahani et al. (14 authors)
Translational research
Published: Sep 2024
9 citations
9 citations
68 days before retraction
A Comparative Review of Tocosomes, Liposomes, and Nanoliposomes as Potent and Novel Nanonutraceutical Delivery Systems for Health and Biomedical Applications
Omar M. Atrooz, Elham Kerdari, M. R. Mozafari et al. (8 authors)
Biomedicines
Open Access
Published: Sep 2024
4 citations
4 citations
75 days before retraction
Withametelin inhibits TGF-β induced Epithelial-to-Mesenchymal Transition and Programmed-Death Ligand-1 expression in vitro
Ashna Fathima, Mohammad Ali Farboodniay Jahromi, A. Sajeli Begum et al. (4 authors)
Frontiers in Oncology
Open Access
Published: Jul 2024
125 days before retraction
Signaling pathways in colorectal cancer implications for the target therapies
Yanlin Song, Ming Chen, Yuhao Wei et al. (5 authors)
Molecular Biomedicine
Open Access
Published: Jun 2024
13 citations
13 citations
163 days before retraction
The therapeutic impact of programmed death – 1 in the treatment of colorectal cancer
Pooria Salehi Sangani, Soroush Yazdani, Ghazaleh Khalili‐Tanha et al. (13 authors)
Pathology - Research and Practice
Published: May 2024
4 citations
4 citations
185 days before retraction
Pathways and molecules for overcoming immunotolerance in metastatic gastrointestinal tumors
Qixin Gan, Yue Li, Yuejun Li et al. (7 authors)
Frontiers in Immunology
Open Access
Published: Apr 2024
2 citations
2 citations
226 days before retraction
Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy as first-line treatment for extensive-stage small cell lung cancer: a meta-analysis based on mixed-effect models
Jian-Qing Zheng, Yujie Deng, Bifen Huang et al. (4 authors)
Frontiers in Medicine
Open Access
Published: Jul 2023
1 citation
1 citation
475 days before retraction
Quick Stats
Total Citations:
12
Years Since Retraction:
1.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025